Skip to main content

Table 1 Baseline characteristics of the study patients

From: Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study

  Transplant group (n = 36) Control group (n = 126) p
Demographic data
 Age (years) 58.3 ± 1.6 72.6 ± 1.1 <0.001
 Male sex, n (%) 26 (72 %) 79 (63 %) 0.33
Cardiovascular risk factors
 Diabetes mellitus, n (%) 14 (39 %) 73 (58 %) 0.025
 Hypertension, n (%) 33 (92 %) 108 (86 %) 0.16
 Current smoking, n (%) 14 (39 %) 60 (48 %) 0.12
 Hypercholesterolemia, n (%) 30 (83 %) 104 (83 %) 0.15
 Body mass index (kg/m2) 25.2 ± 0.8 27.2 ± 0.5 0.05
Biological data
 eGFR (MDRD formula) (mL/min/1.73 m2) 47.9 ± 3.7 39.5 ± 2.9 0.15
 Anemia (Hb <12.5 g/dL), n (%) 17 (47 %) 68 (54 %) 0.47
 CRP (mg/dL) 7.6 ± 1.5 25.4 ± 4.1 0.02
  1. Data are expressed as means ± SD or counts (percentages), as appropriate. Abbreviations: eGFR estimated glomerular filtration rate, MDRD modification of diet in renal disease, Hb hemoglobin, CRP C-reactive protein